Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1157781Generated: October 31, 2026

Sodium hydride → HCID 59511480, compound

https://huagongshe.com/reaction/1157781

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium hydrideHCID 24758—
ReactantMethyl bromoacetateHCID 60984—
ReactantHCID 178493711HCID 178493711—
SolventDimethylformamideHCID 6228—
ProductHCID 59511480HCID 59511480—

Reaction Steps

To a solution of 1-(4-methoxy-7-(1H-pyrazol-3-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-(4-(1-(pyridin-2-yl)-1H-tetrazol-5-yl)piperazin-1-yl)ethane-1,2-dione (0.207 g, 0.414 mmol) in DMF (2 mL) was added NaH (0.083 g, 2.072 mmol). The mixture was stirred for 5 minutes at rt and methyl bromoacetate (0.047 mL, 0.497 mmol) was added. The mixture was stirred at rt for 30 minutes. LC/MS showed starting material still present, so an additional 0.05 mL of methyl bromoacetate was added. The mixture was stirred for 1 h at rt, and was quenched with water. The solvent was removed under reduced pressure, and the residue was partitioned with water and dichloromethane. The aqueous layer was acidified to pH=1 using 0.1N HCl. The solids that formed were collected by filtration, dissolved in DMF, and were purified by prep HPLC. The aqueous layer containing the remainder of the material was concentrated under reduced pressure, and was dissolved in DMF. The DMF solution was filtered through a plug of celite to remove solids, and the DMF solution was purified by prep HPLC. A second prep HPLC run was used to purify the product. 2-(7-(1-(carboxymethyl)-1H-pyrazol-3-yl)-4-methoxy-3-(2-oxo-2-(4-(1-(pyridin-2-yl)-1H-tetrazol-5-yl)piperazin-1-yl)acetyl)-1H-pyrrolo[2,3-c]pyridin-1-yl)acetic acid was isolated as a light-yellow solid (0.032 g, 0.052 mmol, 12.5% yield). 1H NMR (500 MHz, DMSO-D6) δ ppm 8.65-8.69 (m, 1H) 8.50 (s, 1H) 8.13-8.19 (m, 2H) 7.92 (s, 1H) 7.85 (d, J=7.93 Hz, 1H) 7.64 (dd, J=7.63, 4.88 Hz, 1H) 6.65 (s, 1H) 5.17 (s, 2H) 5.05 (s, 2H) 4.01 (s, 3H) 3.72 (s, 2H) 3.45 (dd, J=11.60, 3.05 Hz, 4H) 3.29 (d, J=3.36 Hz, 2H). LCMS: m/e 616.34 (M+H)+, ret time 1.565 min (method 4). 2-(3-(4-methoxy-3-(2-oxo-2-(4-(1-(pyridin-2-yl)-1H-tetrazol-5-yl)piperazin-1-yl)acetyl)-1H-pyrrolo[2,3-c]pyridin-7-yl)-1H-pyrazol-1-yl)acetic acid was isolated as an off-white solid (0.132 g, 0.237 mmol, 52.1% yield). 1H NMR (500 MHz, DMSO-D6) δ ppm 1H NMR (500 MHz, DMSO-D6) d ppm 12.37 (s, 1H) 8.65-8.68 (m, 1H) 8.32 (s, 1H) 8.13-8.18 (m, 1H) 8.07 (s, 1H) 7.96 (d, J=2.44 Hz, 1H) 7.85 (d, J=7.93 Hz, 1H) 7.64 (dd, J=7.48, 4.73 Hz, 1H) 7.03 (d, J=1.83 Hz, 1H) 5.17-5.20 (m, 2H) 4.01 (s, 3H) 3.70-3.75 (m, 2H) 3.40-3.49 (m, 4H) 3.24-3.29 (m, 2H). LCMS: m/e 558.19 (M+H)+, ret time 0.955 min (method 3).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07807676B2
Source datasetuspto-grants-2010_10
ORD IDord-56121fda4d7f435e952fcdaea70ef030
Source noteuspto-grants-2010_10